Preston Klassen - President & Head of R & D, Director at Regulus Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & Head of R & D, Director
Stock Symbol
RGLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Preston Klassen since 7/7/2023

Holdings reported by Preston Klassen for Regulus Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 528,000 May 20, 2024 Direct Common Stock

Transactions reported by Preston Klassen for Regulus Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership